Breakthrough in Cancer Gene Therapy: Micro/Nano Motors Hold Promise for Targeted Drug Delivery

Strategic Insights -

Researchers from Chuo University in Tokyo, Japan, have made a significant breakthrough in cancer gene therapy by developing micro/nano motors that can deliver targeted drugs to cancer cells. These self-propelled micro motors, functionalized with doxorubicin-loaded liposomes, can be triggered to release the drug upon near-infrared irradiation, leading to efficient cell death. The study, supported by the Japan Society for the Promotion of Science and Grants-in-Aid for Scientific Research, has the potential to revolutionize cancer treatment.

Key Takeaways:

  • The researchers developed urease-powered polymer tube micromotors functionalized with doxorubicin-loaded liposomes, which can be triggered to release the drug upon near-infrared irradiation.
  • The micromotors exhibited autonomous propulsion in a urea solution while retaining surface-adsorbed liposomes, and were able to deliver the drug to cancer cells with high efficacy.
  • The study demonstrated that the micromotors can be used as a promising biotechnological tool for precision-targeted cancer therapy, offering high-capacity drug loading and light-responsive, on-demand release.
  • The research was supported by the Japan Society for the Promotion of Science and Grants-in-Aid for Scientific Research (KAKENHI), and was conducted in collaboration with the JST SPRING program.
  • The study has the potential to improve cancer treatment outcomes by increasing the efficacy of targeted drug delivery and reducing side effects.

Statistics:

  • The micromotors were able to deliver the drug with high efficacy, resulting in 80% cell death in breast cancer cells.
  • The study demonstrated that the micromotors can be triggered to release the drug upon near-infrared irradiation, resulting in rapid Dox release and efficient cell death.
  • The research has the potential to revolutionize cancer treatment and improve patient outcomes, with the goal of reducing chemotherapy-related side effects.
  • The study was conducted by researchers from Chuo University, Faculty of Science and Engineering, Department of Applied Chemistry, Tokyo 1128551, Japan.

Sources:

  • "Tubular Micromotors Functionalized With Doxorubicin-loaded Liposomes for Drug Delivery and Light-triggered Release." ACS Applied Nano Materials, 2025.
  • Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI).
  • JST SPRING program.
  • NewsRx LLC. "Findings from Chuo University Yields New Data on Cancer Gene Therapy (Tubular Micromotors Functionalized With Doxorubicin-loaded Liposomes for Drug Delivery and Light-triggered Release)." Cancer Weekly. July 1, 2025; p 22.